CASI Pharmaceuticals logo
CASI Pharmaceuticals CASI

Quarterly report 2022-Q3
added 11-14-2022

report update icon

CASI Pharmaceuticals Total Current Liabilities 2011-2026 | CASI

Annual Total Current Liabilities CASI Pharmaceuticals

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
13.2 M 7.98 M 7.95 M 3.87 M 5.06 M 1.32 M 1.05 M 919 K 565 K 743 K 704 K

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
13.2 M 565 K 3.94 M

Total Current Liabilities of other stocks in the Biotechnology industry

Issuer Total Current Liabilities Price % 24h Market Cap Country
Acorda Therapeutics Acorda Therapeutics
ACOR
228 M - -24.86 % $ 820 K usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
22.9 M - - $ 86.2 M usaUSA
Amgen Amgen
AMGN
25.5 B $ 345.02 1.52 % $ 186 B usaUSA
AlloVir AlloVir
ALVR
9.71 M - 4.14 % $ 49.1 M usaUSA
Amneal Pharmaceuticals Amneal Pharmaceuticals
AMRX
882 M $ 12.59 2.19 % $ 3.95 B usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
15.1 M - - $ 10.1 M usaUSA
Applied Therapeutics Applied Therapeutics
APLT
71.2 M - - $ 8.42 M usaUSA
I-Mab I-Mab
IMAB
576 M - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
1.62 B - - $ 40.3 B usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
130 M $ 23.65 1.63 % $ 3.01 B usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
73.4 M $ 1.43 4.78 % $ 381 M britainBritain
AVROBIO AVROBIO
AVRO
6.35 M - 1083.1 % $ 745 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
7.54 M - - $ 7.46 M israelIsrael
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
1.77 M - -1.52 % $ 24.7 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
1.83 B - 0.49 % $ 251 B cayman-islandsCayman-islands
CymaBay Therapeutics CymaBay Therapeutics
CBAY
36.8 M - - $ 3.45 B usaUSA
Advaxis Advaxis
ADXS
25 M - -9.65 % $ 45.9 M usaUSA
Aytu BioScience Aytu BioScience
AYTU
63.1 M $ 2.66 3.5 % $ 16.7 M usaUSA
Avid Bioservices Avid Bioservices
CDMO
70.6 M - - $ 789 M usaUSA
Cidara Therapeutics Cidara Therapeutics
CDTX
49.6 M - - $ 1.41 B usaUSA
Cabaletta Bio Cabaletta Bio
CABA
50.2 M $ 3.1 0.97 % $ 311 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
556 M - - - russiaRussia
Checkpoint Therapeutics Checkpoint Therapeutics
CKPT
20.1 M - - $ 169 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
2.05 M $ 3.03 - $ 6.59 B israelIsrael
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
9.38 M - - $ 231 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
3.56 M - -10.17 % $ 12.2 K usaUSA
Cerus Corporation Cerus Corporation
CERS
101 M $ 1.95 5.99 % $ 372 M usaUSA
Concert Pharmaceuticals Concert Pharmaceuticals
CNCE
16.1 M - - $ 401 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
58.7 M - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
25.2 M - - $ 26.5 M usaUSA
Cellectar Biosciences Cellectar Biosciences
CLRB
4.75 M $ 2.8 1.82 % $ 7.3 M usaUSA
CTI BioPharma Corp. CTI BioPharma Corp.
CTIC
81.1 M - - $ 1.2 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
1.61 M - 1.93 % $ 17.4 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
9.31 M - -45.71 % $ 1.2 M canadaCanada
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
1.33 M - -4.36 % $ 27 M usaUSA
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
100 M - - $ 2.18 B usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
39.8 M - - $ 3.67 B usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
78.6 M - - $ 2.02 B usaUSA
Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings
CRBP
20.7 M $ 9.61 -1.06 % $ 128 M usaUSA